Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
Kidney InjuryContrast-induced Nephropathy
Interventions
DIAGNOSTIC_TEST

Early kidney damage biomarkers

In the urine samples of these patients, a series of biomarkers of early kidney damage and / or predisposition to kidney damage will be measured

DIAGNOSTIC_TEST

Predisposition to kidney injury biomarkers

In the urine samples of these patients, a series of biomarkers of predisposition to kidney damage will be measured

Trial Locations (1)

37009

Servicio de Cardiología del CAUSA, Salamanca

All Listed Sponsors
collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

collaborator

Salamanca University Hospital

OTHER

collaborator

University of Salamanca

OTHER

lead

R. Laura Vicente Vicente

OTHER

NCT04225013 - Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy | Biotech Hunter | Biotech Hunter